Geron Corp SEC filings GERN
Geron Corp has 1,002 filings in SEC EDGAR's recent list, going back to Nov 16, 2009. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SEC STAFF LETTER | Filing | Mar 5, 2021 | — |
| SEC STAFF LETTER | Filing | Feb 4, 2021 | — |
| EFFECT | Filing | Nov 6, 2020 | — |
| CORRESP | Letter to the SEC | Nov 4, 2020 | — |
| CORRESP | Letter to the SEC | Oct 9, 2020 | — |
| CORRESP | Letter to the SEC | Oct 7, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2020 | — |
| CT ORDER | Filing | May 3, 2019 | — |
| EFFECT | Filing | Jul 12, 2018 | — |
| CORRESP | Letter to the SEC | Jul 10, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 5, 2018 | — |
| CT ORDER | Filing | Dec 16, 2016 | — |
| EFFECT | Filing | Sep 11, 2015 | — |
| CORRESP | Letter to the SEC | Sep 10, 2015 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2015 | — |
| CT ORDER | Filing | May 26, 2015 | — |
| DFAN14A | Current report | Jan 8, 2013 | — |
| DFAN14A | Definitive additional proxy soliciting materials filed by non-management | Jan 7, 2013 | — |
| 425 | Biotime, inc. 425 | Oct 18, 2012 | — |
| EFFECT | Filing | Oct 11, 2012 | — |
| CORRESP | Letter to the SEC | Oct 9, 2012 | — |
| CT ORDER | Filing | Aug 15, 2012 | — |
| UPLOAD | Letter from the SEC | Aug 10, 2012 | — |
| CORRESP | Letter to the SEC | Jul 26, 2012 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2012 | — |
| UPLOAD | Letter from the SEC | Jul 12, 2012 | — |
| DEFR14A | Definitive revised proxy soliciting materials | Apr 24, 2012 | — |
| CT ORDER | Filing | Apr 2, 2012 | — |
| CT ORDER | Filing | Nov 16, 2011 | — |
| CT ORDER | Filing | Apr 13, 2011 | — |
| EFFECT | Filing | Jan 13, 2011 | — |
| EFFECT | Filing | Sep 8, 2010 | — |
| EFFECT | Filing | Apr 26, 2010 | — |
| EFFECT | Filing | Feb 11, 2010 | — |
| EFFECT | Filing | Jan 20, 2010 | — |
| EFFECT | Filing | Dec 3, 2009 | — |
| CORRESP | Letter to the SEC | Dec 2, 2009 | — |
| UPLOAD | Letter from the SEC | Dec 2, 2009 | — |
| CORRESP | Letter to the SEC | Nov 23, 2009 | — |
| UPLOAD | Letter from the SEC | Nov 23, 2009 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GERN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Foster City, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 886744
- Former names
- GERON CORPORATION (until Aug 5, 2005)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.